Observations on the effects of protease inhibitors on the suppression of experimental allergic encephalomyelitis.
Inhibitors of proteolytic enzymes were tested for their ability to suppress the clinical signs and CNS lesions produced by injection of purified myelin in complete Freund's adjuvant into Lewis rats. Pepstatin or a series of neutral protease inhibitors including aprotinin, soybean trypsin inhibitor, leupeptin, antipain, trans-aminomethyl cyclohexane carboxylic acid (AMCA), epsilon-amino caproic acid (EACA) nitrophenyl guanidino benzoate (NPGB), D- and L-polylysine, or a new commercial protease inhibitor, dipropionyl Rhein (DPR) were injected daily beginning on day 7 after immunization of rats with myelin. Aprotinin and soybean trypsin inhibitor exacerbated the symptoms and lesions of experimental allergic encephalomyelitis (EAE), leupeptin and antipain had no effect, and the plasminogen activators AMCA, EACA, NPGB, as well as poly-L- and poly-D-lysine and DPR suppressed various aspects of EAE. The measurement of acid protease as a biochemical method for quantitation of the degree of cellular infiltration into the CNS is proposed, and the results with the various treatments presented. AMCA and NPGB may exert their effects at the site of entrance of the lymphoid cells into the CNS.
D015119:Aminocaproic Acid / Q000627:therapeutic use; D000818:Animals; D000880:Anthraquinones / Q000627:therapeutic use; D001565:Benzoates / Q000627:therapeutic use; D001835:Body Weight / Q000187:drug effects; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000188:drug therapy* / Q000201:enzymology; D010436:Pepstatins / Q000627:therapeutic use; D010447:Peptide Hydrolases / Q000378:metabolism; D011107:Polylysine / Q000627:therapeutic use; D011480:Protease Inhibitors / Q000627:therapeutic use*; D051381:Rats; D011917:Rats, Inbred Lew; D013116:Spinal Cord / Q000201:enzymology; D014148:Tranexamic Acid / Q000627:therapeutic use
D000880:Anthraquinones; D001565:Benzoates; D010436:Pepstatins; D011480:Protease Inhibitors; C002238:4-nitrophenyl 4'-guanidinobenzoate; D011107:Polylysine; D014148:Tranexamic Acid; D010447:Peptide Hydrolases; D015119:Aminocaproic Acid; C020491:rhein